Treace Medical Concepts (TMCI) Revenue & Revenue Breakdown
Treace Medical Concepts Revenue Highlights
Latest Revenue (Y)
$209.36M
Latest Revenue (Q)
$52.57M
Treace Medical Concepts Revenue by Period
Treace Medical Concepts Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $209.36M | 11.89% |
| 2023-12-31 | $187.12M | 31.92% |
| 2022-12-31 | $141.84M | 50.22% |
| 2021-12-31 | $94.42M | 64.59% |
| 2020-12-31 | $57.37M | 45.54% |
| 2019-12-31 | $39.42M | - |
Treace Medical Concepts generated $209.36M in revenue during NA 2024, up 11.89% compared to the previous quarter, and up 531.15% compared to the same period a year ago.
Treace Medical Concepts Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $52.57M | -23.49% |
| 2024-12-31 | $68.71M | 52.39% |
| 2024-09-30 | $45.09M | 1.42% |
| 2024-06-30 | $44.45M | -13.02% |
| 2024-03-31 | $51.11M | -17.85% |
| 2023-12-31 | $62.21M | 52.64% |
| 2023-09-30 | $40.76M | -2.85% |
| 2023-06-30 | $41.95M | -0.57% |
| 2023-03-31 | $42.20M | -15.22% |
| 2022-12-31 | $49.77M | 50.56% |
| 2022-09-30 | $33.05M | 10.30% |
| 2022-06-30 | $29.97M | 3.17% |
| 2022-03-31 | $29.05M | -13.13% |
| 2021-12-31 | $33.44M | 54.67% |
| 2021-09-30 | $21.62M | 4.67% |
| 2021-06-30 | $20.65M | 10.41% |
| 2021-03-31 | $18.71M | -22.39% |
| 2020-12-31 | $24.11M | 68.97% |
| 2020-09-30 | $14.27M | 84.34% |
| 2020-06-30 | $7.74M | -31.25% |
| 2020-03-31 | $11.26M | - |
Treace Medical Concepts generated $52.57M in revenue during Q1 2025, up -23.49% compared to the previous quarter, and up 84.50% compared to the same period a year ago.
Treace Medical Concepts Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TOI | Oncology Institute | $393.41M | $104.41M |
| TMCI | Treace Medical Concepts | $209.36M | $52.57M |
| KIDS | OrthoPediatrics | $204.73M | $61.08M |
| RXST | RxSight | $139.93M | $37.90M |
| SRDX | Surmodics | $126.08M | $28.09M |
| NPCE | NeuroPace | $79.91M | $23.52M |
| SMLR | Semler Scientific | $56.29M | $8.22M |
| DCTH | Delcath Systems | $31.02M | - |
| CATX | Perspective Therapeutics | $1.43M | - |
| DSGN | Design Therapeutics | - | - |